Co Located with BioPharma Development and Production Week, the Biotech Investment Summit will bring together top deal makers from local and international financial markets, and the biotech industry. Central to the conference objectives will be connecting investors with biotech, against the backdrop of company showcases, emerging market opportunities and a specific focus on China. In addition, practical tools for investment appraisal, due diligence and deal structuring tactics will be discussed.
Showcase your company!
Are you an investor, or biotech company seeking finance? Contact us with a brief pitch to make your case for being a speaker.
Discussion topics being explored:
- Global and Asian investment and financing trends
- Mega Trends and Innovation – what’s happening in Biotech and how will it impact investment flow
- Investor psychology – perspectives from VCs, Funds, PE and Institutional investors
- Segmenting the investment opportunities – where is the money?
- Divestiture and M&A trends, and what to expect
- IPO outlook
- Company showcase from emerging markets
- Evaluating and investing in China based companies
- Small biotech showcase and shareholding opportunities
- Financing clinical trials
- Raising finance for greenfield manufacturing site projects
- Pitching your company to investors
- Due diligence of biotech companies
- Regulatory considerations and Antitrust law for biotech
- Deal Structuring
Choose your language
Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.
Vice-President, Research & Development, Amgen, China
Dr. Carl Firth
Founder and Chief Executive Officer, Aslan Pharmaceuticals Pte Ltd, Singapore
Chief Executive Officer, Hummingbird Bioscience, Singapore
PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China
Head of Logistics - APAC, Teva
Head of Bioprocess Development, Sanofi, France
Dr Damian Tan
Managing Director, Vickers Venture Partners Singapore
Dr. Ming-Chu Hsu
Chairman and Chief Executive Officer, TaiGen Biotechnology, Taiwan
Co-Founder, Chief Executive Officer, Board Director, Engine Bioscience, Singapore
Chief Executive Officer, SyneuRx International (Taiwan) Corp
CEO/CSO, Denovo Biopharma LLC, U.S.
Dr. Li Zhu
Chief Strategy Officer, GenScript and Legend Biotech, China
Dr. Poon Thong Yuen
Chief Strategy Officer, Histoindex, Singapore
Managing Director & CEO, Invion Limited, Australia
Dr. Lim Xinhong
Venture Principal, Vickers Venture Partners Singapore
Senior Vice President, DBS Bank, Singapore
Managing Director, Quan Capital, China
Chief Executive Officer, Lightstone Singapore
Neo Kah Yean
Senior Vice President, Commercialisation for Biomedical Sciences ETPL A*STAR
Venkateswarlu Nelabhotla (N. Venkat)
CEO & Board Member, VYOME India
Chief Executive Officer, AUM Biosciences, Singapore
Dr. Lietao LI
Chief Executive Officer, LION TCR, Singapore
Chief Technical Officer – Engineering and Projects, AJ Pharma Holding, Malaysia
Vice President of Biologics Development and Manufacturing, WuXi Biologics, China
Still have a question?